Apotex Exits Forest's Patent Suit Over Generic Savella
Forest Laboratories Inc. agreed Wednesday to drop its claims that Apotex Inc. infringed three patents covering fibromyalgia treatment Savella after the generics manufacturer agreed that its application to the U.S. Food...To view the full article, register now.
Already a subscriber? Click here to view full article